What We're Reading: Page 392
Industry reads hand-picked by our editors
Mar 27, 2015
-
Wall Street Journal
WHO suggest EU cooperation to lower Rx prices
-
Yahoo News
EU approves Orexigen obesity treatment
-
Bloomberg
J&J, Google to team up on robotic surgeries
-
HHS
HHS' plan to fight opioid drug overdoses
Mar 26, 2015
-
Reuters
British prime minister apologizes for infected blood during 70s and 80s for hemophiliacs
-
Bloomberg
Novartis CEO says that it's ok (and right) to drop investigational products that aren't working
-
The Street
Celladon heart failure study looms large
-
Yahoo Finance
Regulus nabs orphan designation from EU for RG-102 for Alport Syndrome
-
Sun Pharma: After Ranbaxy buyout, we'll work hard to regain regulators' trust
Mar 25, 2015
-
In-Pharmatechnologist
The FDA's new plans for inspections in India
-
Wall Street Journal
Compounding pharmacist trade group discourages supplying lethal injection meds
-
Irish Times
Pharmacyclics execs to rake in $4 billion after AbbVie sale
-
Bloomberg
Vertex cystic fibrosis drug disappoints in trial
-
FiercePharma
The surprising disease that's spiking Rx spending
Mar 24, 2015
-
Reuters
Merck Keytruda melanoma study halted after drug meets goal
-
Bloomberg
Does Biogen have its Alzheimer's target straight?
-
FiercePharma
Daiichi Sankyo chopping its HQ staff by 16%
-
Medical Marketing & Media
Pharma DTC marketing skyrockets in 2014
Mar 23, 2015
-
Deccan Herald
Indian high court rules for Merck in patent dispute
-
In-Pharmatechnologist
Former Shire, Boehringer CEOs join board of women's health company
-
Reuters
Pfizer, Lilly to resume study testing pain drug
-
Nasdaq
Amgen submits PCSK9 drug in Japan
-
Pharma Times
Pfizer psoriasis drug hits phase III targets
Mar 20, 2015
Mar 19, 2015
-
ABC News
AbbVie seeks $30 million expansion in Puerto Rico
-
Science Blogs
Scientists slam NYT article warning of Apple Watch cancer risks
-
Bloomberg
Former Salix execs who left under controversy nab big golden parachutes
-
Reuters
Sanofi research head: Global drug regulation rifts hurting biopharma
-
FiercePharma
Outgoing Bristol-Myers chief walking out with $27 million
Previous
